Search research articles
Contact Us
Filters
Showing results (11-20 of 107) with videos related to
Page
of 11
Sort By:
European Journal of Haematology
|
February 28, 2014
Blastic plasmacytoid dendritic cell neoplasm: the first report of two cases treated by 5-azacytidine
Kamel Laribi, Nathalie Denizon, Habib Ghnaya, et al.
Cancer Treatment and Research Communications
|
December 1, 2023
Fatigue visual analogue scale score correlates with quality of life in cancer patients receiving epoetin alfa (Sandoz) for chemotherapy-induced anaemia: The CIROCO study
Jerome Desramé, Nathalie Baize, Amélie Anota, et al.
Annales De Biologie Clinique
|
August 7, 2018
[Shwachman-Diamond syndrome: a case report]
Mohamed Kaabar, Pierre Lemaire, Vincent Cussac, et al.
Bulletin Du Cancer
|
October 13, 2022
[Waldenström disease: News and perspectives in 2022]
Florian Bouclet, Daphné Krzisch, Véronique Leblond, et al.
Clinical Case Reports
|
January 20, 2016
Quadri-lineage disease involving nodal B-cell marginal zone lymphoma, high-grade B-cell lymphoma, Kaposi's syndrome, and acute myeloid leukemia
Kamel Laribi, Habib Ghnaya, Pierre-Jean Mention, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 31, 2016
Blastic Plasmacytoid Dendritic Cell Neoplasm: From Origin of the Cell to Targeted Therapies
Kamel Laribi, Nathalie Denizon, Anne Besançon, et al.
Cancer Medicine
|
April 18, 2019
Impact of the relative dose intensity on survival of patients with high-risk myelodysplastic syndromes treated with Azacitidine
Kamel Laribi, Delphine Bolle, Mustafa Alani, et al.
Experimental Hematology
|
June 9, 2018
Prognostic impact of elevated pretreatment serum ferritin in patients with high-risk MDS treated with azacitidine
Kamel Laribi, Delphine Bolle, Mustapha Alani, et al.
Annals of Hematology
|
February 10, 2016
Rituximab is an effective and safe treatment of relapse in elderly patients with resistant warm AIHA
Kamel Laribi, Delphine Bolle, Habib Ghnaya, et al.
Annals of Hematology
|
August 4, 2016
R-CVP regimen is active in frail elderly patients aged 80 or over with diffuse large B cell lymphoma
Kamel Laribi, Nathalie Denizon, Delphine Bolle, et al.
Page
of 11
Search research articles
Search
Showing results (11-20 of 107) with videos related to
Sort By:
Page
of 11
European Journal of Haematology
|
February 28, 2014
Blastic plasmacytoid dendritic cell neoplasm: the first report of two cases treated by 5-azacytidine
Kamel Laribi, Nathalie Denizon, Habib Ghnaya, et al.
Cancer Treatment and Research Communications
|
December 1, 2023
Fatigue visual analogue scale score correlates with quality of life in cancer patients receiving epoetin alfa (Sandoz) for chemotherapy-induced anaemia: The CIROCO study
Jerome Desramé, Nathalie Baize, Amélie Anota, et al.
Annales De Biologie Clinique
|
August 7, 2018
[Shwachman-Diamond syndrome: a case report]
Mohamed Kaabar, Pierre Lemaire, Vincent Cussac, et al.
Bulletin Du Cancer
|
October 13, 2022
[Waldenström disease: News and perspectives in 2022]
Florian Bouclet, Daphné Krzisch, Véronique Leblond, et al.
Clinical Case Reports
|
January 20, 2016
Quadri-lineage disease involving nodal B-cell marginal zone lymphoma, high-grade B-cell lymphoma, Kaposi's syndrome, and acute myeloid leukemia
Kamel Laribi, Habib Ghnaya, Pierre-Jean Mention, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 31, 2016
Blastic Plasmacytoid Dendritic Cell Neoplasm: From Origin of the Cell to Targeted Therapies
Kamel Laribi, Nathalie Denizon, Anne Besançon, et al.
Cancer Medicine
|
April 18, 2019
Impact of the relative dose intensity on survival of patients with high-risk myelodysplastic syndromes treated with Azacitidine
Kamel Laribi, Delphine Bolle, Mustafa Alani, et al.
Experimental Hematology
|
June 9, 2018
Prognostic impact of elevated pretreatment serum ferritin in patients with high-risk MDS treated with azacitidine
Kamel Laribi, Delphine Bolle, Mustapha Alani, et al.
Annals of Hematology
|
February 10, 2016
Rituximab is an effective and safe treatment of relapse in elderly patients with resistant warm AIHA
Kamel Laribi, Delphine Bolle, Habib Ghnaya, et al.
Annals of Hematology
|
August 4, 2016
R-CVP regimen is active in frail elderly patients aged 80 or over with diffuse large B cell lymphoma
Kamel Laribi, Nathalie Denizon, Delphine Bolle, et al.
Page
of 11